 | • レポートコード：GIR-107A12296 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝的ウイルスベクターのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝的ウイルスベクターの種類別市場規模（レトロウイルスベクター、アデノウイルスベクター、アデノ随伴ウイルスベクター、その他）、用途別市場規模（遺伝子治療、ワクチン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝的ウイルスベクターの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：FUJIFILM Diosynth Biotechnologies U.S.A.、Sanofi、Lonza、Merck KGaA、GENERAL ELECTRIC COMPANY、Oxford BioMedica、Spark Therapeutics, Inc.、uniQure N.V.、FinVector Vision Therapies、Brammer Bio、Cell and Gene Therapy Catapult、Cobra Biologics、REGENXBIO Inc.、Kaneka Eurogentec S.A. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：レトロウイルスベクター、アデノウイルスベクター、アデノ随伴ウイルスベクター、その他 ・用途別分析2016年-2026年：遺伝子治療、ワクチン ・遺伝的ウイルスベクターの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝的ウイルスベクターのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝的ウイルスベクターのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝的ウイルスベクターの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝的ウイルスベクターの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Genetic Virus Vector market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Genetic Virus Vector size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Genetic Virus Vector market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Genetic Virus Vector market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Retroviral Vectors
Adenoviral Vectors
Adeno-Associated Viral Vectors
Other
Market segment by Application, can be divided into
Gene Therapy
Vaccinology
Market segment by players, this report covers
FUJIFILM Diosynth Biotechnologies U.S.A.
Sanofi
Lonza
Merck KGaA
GENERAL ELECTRIC COMPANY
Oxford BioMedica
Spark Therapeutics, Inc.
uniQure N.V.
FinVector Vision Therapies
Brammer Bio
Cell and Gene Therapy Catapult
Cobra Biologics
REGENXBIO Inc.
Kaneka Eurogentec S.A.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genetic Virus Vector product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Virus Vector, with revenue, gross margin and global market share of Genetic Virus Vector from 2019 to 2021.
Chapter 3, the Genetic Virus Vector competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Genetic Virus Vector market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Genetic Virus Vector research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Genetic Virus Vector
1.2 Classification of Genetic Virus Vector by Type
1.2.1 Overview: Global Genetic Virus Vector Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Genetic Virus Vector Revenue Market Share by Type in 2020
1.2.3 Retroviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Adeno-Associated Viral Vectors
1.2.6 Other
1.3 Global Genetic Virus Vector Market by Application
1.3.1 Overview: Global Genetic Virus Vector Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Global Genetic Virus Vector Market Size & Forecast
1.5 Global Genetic Virus Vector Market Size and Forecast by Region
1.5.1 Global Genetic Virus Vector Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Genetic Virus Vector Market Size by Region, (2016-2021)
1.5.3 North America Genetic Virus Vector Market Size and Prospect (2016-2026)
1.5.4 Europe Genetic Virus Vector Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Genetic Virus Vector Market Size and Prospect (2016-2026)
1.5.6 South America Genetic Virus Vector Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Genetic Virus Vector Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Virus Vector Market Drivers
1.6.2 Genetic Virus Vector Market Restraints
1.6.3 Genetic Virus Vector Trends Analysis
2 Company Profiles
2.1 FUJIFILM Diosynth Biotechnologies U.S.A.
2.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Details
2.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Major Business
2.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product and Solutions
2.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Genetic Virus Vector Product and Solutions
2.2.4 Sanofi Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Lonza
2.3.1 Lonza Details
2.3.2 Lonza Major Business
2.3.3 Lonza Genetic Virus Vector Product and Solutions
2.3.4 Lonza Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Lonza Recent Developments and Future Plans
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA Genetic Virus Vector Product and Solutions
2.4.4 Merck KGaA Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck KGaA Recent Developments and Future Plans
2.5 GENERAL ELECTRIC COMPANY
2.5.1 GENERAL ELECTRIC COMPANY Details
2.5.2 GENERAL ELECTRIC COMPANY Major Business
2.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Product and Solutions
2.5.4 GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GENERAL ELECTRIC COMPANY Recent Developments and Future Plans
2.6 Oxford BioMedica
2.6.1 Oxford BioMedica Details
2.6.2 Oxford BioMedica Major Business
2.6.3 Oxford BioMedica Genetic Virus Vector Product and Solutions
2.6.4 Oxford BioMedica Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Oxford BioMedica Recent Developments and Future Plans
2.7 Spark Therapeutics, Inc.
2.7.1 Spark Therapeutics, Inc. Details
2.7.2 Spark Therapeutics, Inc. Major Business
2.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Product and Solutions
2.7.4 Spark Therapeutics, Inc. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Spark Therapeutics, Inc. Recent Developments and Future Plans
2.8 uniQure N.V.
2.8.1 uniQure N.V. Details
2.8.2 uniQure N.V. Major Business
2.8.3 uniQure N.V. Genetic Virus Vector Product and Solutions
2.8.4 uniQure N.V. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 uniQure N.V. Recent Developments and Future Plans
2.9 FinVector Vision Therapies
2.9.1 FinVector Vision Therapies Details
2.9.2 FinVector Vision Therapies Major Business
2.9.3 FinVector Vision Therapies Genetic Virus Vector Product and Solutions
2.9.4 FinVector Vision Therapies Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 FinVector Vision Therapies Recent Developments and Future Plans
2.10 Brammer Bio
2.10.1 Brammer Bio Details
2.10.2 Brammer Bio Major Business
2.10.3 Brammer Bio Genetic Virus Vector Product and Solutions
2.10.4 Brammer Bio Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Brammer Bio Recent Developments and Future Plans
2.11 Cell and Gene Therapy Catapult
2.11.1 Cell and Gene Therapy Catapult Details
2.11.2 Cell and Gene Therapy Catapult Major Business
2.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Product and Solutions
2.11.4 Cell and Gene Therapy Catapult Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans
2.12 Cobra Biologics
2.12.1 Cobra Biologics Details
2.12.2 Cobra Biologics Major Business
2.12.3 Cobra Biologics Genetic Virus Vector Product and Solutions
2.12.4 Cobra Biologics Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Cobra Biologics Recent Developments and Future Plans
2.13 REGENXBIO Inc.
2.13.1 REGENXBIO Inc. Details
2.13.2 REGENXBIO Inc. Major Business
2.13.3 REGENXBIO Inc. Genetic Virus Vector Product and Solutions
2.13.4 REGENXBIO Inc. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 REGENXBIO Inc. Recent Developments and Future Plans
2.14 Kaneka Eurogentec S.A.
2.14.1 Kaneka Eurogentec S.A. Details
2.14.2 Kaneka Eurogentec S.A. Major Business
2.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Product and Solutions
2.14.4 Kaneka Eurogentec S.A. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Kaneka Eurogentec S.A. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Genetic Virus Vector Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Virus Vector Players Market Share
3.2.2 Top 10 Genetic Virus Vector Players Market Share
3.2.3 Market Competition Trend
3.3 Genetic Virus Vector Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Genetic Virus Vector Revenue and Market Share by Type (2016-2021)
4.2 Global Genetic Virus Vector Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Genetic Virus Vector Revenue Market Share by Application (2016-2021)
5.2 Genetic Virus Vector Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Genetic Virus Vector Revenue by Type (2016-2026)
6.2 North America Genetic Virus Vector Revenue by Application (2016-2026)
6.3 North America Genetic Virus Vector Market Size by Country
6.3.1 North America Genetic Virus Vector Revenue by Country (2016-2026)
6.3.2 United States Genetic Virus Vector Market Size and Forecast (2016-2026)
6.3.3 Canada Genetic Virus Vector Market Size and Forecast (2016-2026)
6.3.4 Mexico Genetic Virus Vector Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Genetic Virus Vector Revenue by Type (2016-2026)
7.2 Europe Genetic Virus Vector Revenue by Application (2016-2026)
7.3 Europe Genetic Virus Vector Market Size by Country
7.3.1 Europe Genetic Virus Vector Revenue by Country (2016-2026)
7.3.2 Germany Genetic Virus Vector Market Size and Forecast (2016-2026)
7.3.3 France Genetic Virus Vector Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Genetic Virus Vector Market Size and Forecast (2016-2026)
7.3.5 Russia Genetic Virus Vector Market Size and Forecast (2016-2026)
7.3.6 Italy Genetic Virus Vector Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genetic Virus Vector Revenue by Type (2016-2026)
8.2 Asia-Pacific Genetic Virus Vector Revenue by Application (2016-2026)
8.3 Asia-Pacific Genetic Virus Vector Market Size by Region
8.3.1 Asia-Pacific Genetic Virus Vector Revenue by Region (2016-2026)
8.3.2 China Genetic Virus Vector Market Size and Forecast (2016-2026)
8.3.3 Japan Genetic Virus Vector Market Size and Forecast (2016-2026)
8.3.4 South Korea Genetic Virus Vector Market Size and Forecast (2016-2026)
8.3.5 India Genetic Virus Vector Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Genetic Virus Vector Market Size and Forecast (2016-2026)
8.3.7 Australia Genetic Virus Vector Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Genetic Virus Vector Revenue by Type (2016-2026)
9.2 South America Genetic Virus Vector Revenue by Application (2016-2026)
9.3 South America Genetic Virus Vector Market Size by Country
9.3.1 South America Genetic Virus Vector Revenue by Country (2016-2026)
9.3.2 Brazil Genetic Virus Vector Market Size and Forecast (2016-2026)
9.3.3 Argentina Genetic Virus Vector Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genetic Virus Vector Revenue by Type (2016-2026)
10.2 Middle East & Africa Genetic Virus Vector Revenue by Application (2016-2026)
10.3 Middle East & Africa Genetic Virus Vector Market Size by Country
10.3.1 Middle East & Africa Genetic Virus Vector Revenue by Country (2016-2026)
10.3.2 Turkey Genetic Virus Vector Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Genetic Virus Vector Market Size and Forecast (2016-2026)
10.3.4 UAE Genetic Virus Vector Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Genetic Virus Vector Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Genetic Virus Vector Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Genetic Virus Vector Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Genetic Virus Vector Revenue (USD Million) by Region (2016-2021)
Table 5. Global Genetic Virus Vector Revenue Market Share by Region (2021-2026)
Table 6. FUJIFILM Diosynth Biotechnologies U.S.A. Corporate Information, Head Office, and Major Competitors
Table 7. FUJIFILM Diosynth Biotechnologies U.S.A. Major Business
Table 8. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product and Solutions
Table 9. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Genetic Virus Vector Product and Solutions
Table 13. Sanofi Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Lonza Corporate Information, Head Office, and Major Competitors
Table 15. Lonza Major Business
Table 16. Lonza Genetic Virus Vector Product and Solutions
Table 17. Lonza Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 19. Merck KGaA Major Business
Table 20. Merck KGaA Genetic Virus Vector Product and Solutions
Table 21. Merck KGaA Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GENERAL ELECTRIC COMPANY Corporate Information, Head Office, and Major Competitors
Table 23. GENERAL ELECTRIC COMPANY Major Business
Table 24. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product and Solutions
Table 25. GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Oxford BioMedica Corporate Information, Head Office, and Major Competitors
Table 27. Oxford BioMedica Major Business
Table 28. Oxford BioMedica Genetic Virus Vector Product and Solutions
Table 29. Oxford BioMedica Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Spark Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Spark Therapeutics, Inc. Major Business
Table 32. Spark Therapeutics, Inc. Genetic Virus Vector Product and Solutions
Table 33. Spark Therapeutics, Inc. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. uniQure N.V. Corporate Information, Head Office, and Major Competitors
Table 35. uniQure N.V. Major Business
Table 36. uniQure N.V. Genetic Virus Vector Product and Solutions
Table 37. uniQure N.V. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. FinVector Vision Therapies Corporate Information, Head Office, and Major Competitors
Table 39. FinVector Vision Therapies Major Business
Table 40. FinVector Vision Therapies Genetic Virus Vector Product and Solutions
Table 41. FinVector Vision Therapies Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Brammer Bio Corporate Information, Head Office, and Major Competitors
Table 43. Brammer Bio Major Business
Table 44. Brammer Bio Genetic Virus Vector Product and Solutions
Table 45. Brammer Bio Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Cell and Gene Therapy Catapult Corporate Information, Head Office, and Major Competitors
Table 47. Cell and Gene Therapy Catapult Major Business
Table 48. Cell and Gene Therapy Catapult Genetic Virus Vector Product and Solutions
Table 49. Cell and Gene Therapy Catapult Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Cobra Biologics Corporate Information, Head Office, and Major Competitors
Table 51. Cobra Biologics Major Business
Table 52. Cobra Biologics Genetic Virus Vector Product and Solutions
Table 53. Cobra Biologics Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. REGENXBIO Inc. Corporate Information, Head Office, and Major Competitors
Table 55. REGENXBIO Inc. Major Business
Table 56. REGENXBIO Inc. Genetic Virus Vector Product and Solutions
Table 57. REGENXBIO Inc. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Kaneka Eurogentec S.A. Corporate Information, Head Office, and Major Competitors
Table 59. Kaneka Eurogentec S.A. Major Business
Table 60. Kaneka Eurogentec S.A. Genetic Virus Vector Product and Solutions
Table 61. Kaneka Eurogentec S.A. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Genetic Virus Vector Revenue (USD Million) by Players (2019-2021)
Table 63. Global Genetic Virus Vector Revenue Share by Players (2019-2021)
Table 64. Breakdown of Genetic Virus Vector by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Genetic Virus Vector Players Head Office, Products and Services Provided
Table 66. Genetic Virus Vector Mergers & Acquisitions in the Past Five Years
Table 67. Genetic Virus Vector New Entrants and Expansion Plans
Table 68. Global Genetic Virus Vector Revenue (USD Million) by Type (2016-2021)
Table 69. Global Genetic Virus Vector Revenue Share by Type (2016-2021)
Table 70. Global Genetic Virus Vector Revenue Forecast by Type (2021-2026)
Table 71. Global Genetic Virus Vector Revenue by Application (2016-2021)
Table 72. Global Genetic Virus Vector Revenue Forecast by Application (2021-2026)
Table 73. North America Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Genetic Virus Vector Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Genetic Virus Vector Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Genetic Virus Vector Picture
Figure 2. Global Genetic Virus Vector Revenue Market Share by Type in 2020
Figure 3. Retroviral Vectors
Figure 4. Adenoviral Vectors
Figure 5. Adeno-Associated Viral Vectors
Figure 6. Other
Figure 7. Genetic Virus Vector Revenue Market Share by Application in 2020
Figure 8. Gene Therapy Picture
Figure 9. Vaccinology Picture
Figure 10. Global Genetic Virus Vector Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Genetic Virus Vector Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Genetic Virus Vector Revenue Market Share by Region (2016-2026)
Figure 13. Global Genetic Virus Vector Revenue Market Share by Region in 2020
Figure 14. North America Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Genetic Virus Vector Market Drivers
Figure 20. Genetic Virus Vector Market Restraints
Figure 21. Genetic Virus Vector Market Trends
Figure 22. FUJIFILM Diosynth Biotechnologies U.S.A. Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Lonza Recent Developments and Future Plans
Figure 25. Merck KGaA Recent Developments and Future Plans
Figure 26. GENERAL ELECTRIC COMPANY Recent Developments and Future Plans
Figure 27. Oxford BioMedica Recent Developments and Future Plans
Figure 28. Spark Therapeutics, Inc. Recent Developments and Future Plans
Figure 29. uniQure N.V. Recent Developments and Future Plans
Figure 30. FinVector Vision Therapies Recent Developments and Future Plans
Figure 31. Brammer Bio Recent Developments and Future Plans
Figure 32. Cell and Gene Therapy Catapult Recent Developments and Future Plans
Figure 33. Cobra Biologics Recent Developments and Future Plans
Figure 34. REGENXBIO Inc. Recent Developments and Future Plans
Figure 35. Kaneka Eurogentec S.A. Recent Developments and Future Plans
Figure 36. Global Genetic Virus Vector Revenue Share by Players in 2020
Figure 37. Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Genetic Virus Vector Revenue Market Share in 2020
Figure 39. Global Top 10 Players Genetic Virus Vector Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Genetic Virus Vector Revenue Share by Type in 2020
Figure 42. Global Genetic Virus Vector Market Share Forecast by Type (2021-2026)
Figure 43. Global Genetic Virus Vector Revenue Share by Application in 2020
Figure 44. Global Genetic Virus Vector Market Share Forecast by Application (2021-2026)
Figure 45. North America Genetic Virus Vector Sales Market Share by Type (2016-2026)
Figure 46. North America Genetic Virus Vector Sales Market Share by Application (2016-2026)
Figure 47. North America Genetic Virus Vector Revenue Market Share by Country (2016-2026)
Figure 48. United States Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Genetic Virus Vector Sales Market Share by Type (2016-2026)
Figure 52. Europe Genetic Virus Vector Sales Market Share by Application (2016-2026)
Figure 53. Europe Genetic Virus Vector Revenue Market Share by Country (2016-2026)
Figure 54. Germany Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Genetic Virus Vector Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Genetic Virus Vector Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Genetic Virus Vector Revenue Market Share by Region (2016-2026)
Figure 62. China Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Genetic Virus Vector Sales Market Share by Type (2016-2026)
Figure 69. South America Genetic Virus Vector Sales Market Share by Application (2016-2026)
Figure 70. South America Genetic Virus Vector Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Genetic Virus Vector Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Genetic Virus Vector Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Genetic Virus Vector Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界のウイルスベクターワクチン市場 2021：企業別、地域別、種類・用途別 The Viral Vector Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界のウエストナイルウイルス検査市場 2021：企業別、地域別、種類・用途別 The West Nile Virus Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の遺伝子組み換え市場 2021：企業別、地域別、種類・用途別 The Genetic Modification market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の酵母発現ベクター市場 2021：企業別、地域別、種類・用途別 The Yeast Expression Vector market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界のC型肝炎ウイルスエンベロープタンパク質E2市場 2021：企業別、地域別、種類・用途別 The Hepatitis C Virus Envelope Protein E2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…